Review is not the same as debate, which is the word I deliberately used in the prior post. Please point to a case where a P&T committee has ever rejected the use of an FDA-approved substitutable generic.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”